Cyclic peptides multimers targeting α-4-β-7 integrin
There is described herein, multimers comprising a plurality of compounds covalently linked together, the compounds independently being of formula (I).
1. A multimer selected from the group consisting of a homodimer, a homotrimer and a homotetramer, the multimer comprising two, three or four compounds covalently linked together by a linker selected from the group consisting of an amide linker, an amine linker and a mixed amide/amine linker, the compounds being identical and having the formula (I):
or a pharmaceutically acceptable salt thereof, wherein
R 1 is H, C 1 -C 6 alkyl, aryl, heteroaryl, alkenyl, or heterocycle, all of which are optionally substituted at one or more substitutable positions with one or more substituents selected from the group consisting of hydroxyl, cyano, alkoxy, aryloxy, vinyl, alkenyl, alkynyl, formyl, haloalkyl, halide, aryl, heteroaryl, amide, acyl, ether, thioether, thioalkoxy, phosphino, and —NR a R b , where R a and R b are independently selected from C 1 -C 6 alkyl, aryl or benzyl,
and where the one or more substituents is not alkyl when R 1 is C 1 -C 6 alkyl;
R 2 and R 3 are each independently an amino acid side chain of a proteinogenic or a non-proteinogenic alpha-amino acid,
or R 2 and R 3 are covalently linked to each other to form a ring;
R 4 and R 5 are each independently H, C 1 -C 6 alkyl, aryl, heteroaryl, alkenyl, heterocycle, acids of the formula —C(O)OH, esters of the formula —C(O)OR* wherein R* is selected from alkyl and aryl, amides of the formula —C(O)NR**R***, wherein R** and R*** are independently selected from H, alkyl and aryl; —CH 2 C(O)R, wherein R is selected from —OH, C 1 -C 6 alkyl, aryl, —C 1 -C 6 alkyl-aryl, or —NRaRb, where Ra and Rb are independently selected from H, C 1 -C 6 alkyl, aryl or —C 1 -C 6 alkyl-aryl; or —C(O)Rc, wherein Rc is selected from C 1 -C 6 alkyl, aryl or —C 1 -C 6 alkyl-aryl, or —C 1 -C 6 alkyl-ORd, wherein Rd is a suitable protecting group or OH group; all of which are optionally substituted at one or more substitutable positions with one or more substituents selected from the group consisting of hydroxyl, cyano, alkoxy, aryloxy, vinyl, alkenyl, alkynyl, formyl, haloalkyl, halide, aryl, heteroaryl, amide, acyl, ether, thioether, thioalkoxy, phosphino, and —NR a R b , where R a and R b are independently selected from C 1 -C 6 alkyl, aryl or benzyl;
and where the one or more substituents is not alkyl when R 4 and/or R 5 is C 1 -C 6 alkyl;
or R 2 or R 3 are covalently linked to R 1 to form a cyclic secondary amine, and/or to R 4 or R 5 to form a ring, or R 4 and R 5 are covalently linked to each other to form a ring;
R 6 is H, C 1 -C 6 alkyl, benzyl, alkenyl, C 1 -C 6 alkyloxy, aryl, heteroaryl, heterocycle, —C(O)R****, wherein R**** is independently selected from alkyl, aryl, heteroaryl, amino, aminoalkyl, aminoaryl, aminoheteroaryl, alkoxy, aryloxy, heteroaryloxy; —CH 2 C(O)R, or —C(O)Rc; all of which are optionally substituted at one or more substitutable positions with one or more substituents selected from the group consisting of hydroxyl, cyano, alkoxy, aryloxy, vinyl, alkenyl, alkynyl, formyl, haloalkyl, halide, aryl, heteroaryl, amide, acyl, ether, thioether, thioalkoxy, phosphino, and —NR a R b , where R a and R b are independently selected from C 1 -C 6 alkyl, aryl or benzyl;
and where the one or more substituents is not alkyl when R 6 is C 1 -C 6 alkyl;
or along with R 7 or R 8 , a cyclic side chain of a proteinogenic or a non-proteinogenic amino acid having, the N-terminus thereof being the N—R 6 , wherein the proteinogenic or non-proteinogenic amino acid is optionally substituted with a substituent selected from the group consisting of hydroxyl, cyano, alkoxy, aryloxy, vinyl, alkenyl, alkynyl, formyl, haloalkyl, halide, aryl, heteroaryl, amide, acyl, ether, thioether, thioalkoxy, phosphino, and —NR a R b , where R a and R b are independently selected from C 1 -C 6 alkyl, aryl or benzyl;
R 7 and R 8 are independently selected from the amino acid side chains of a proteinogenic or a non-proteinogenic alpha-amino acid having the N-terminus thereof being the N—R 6 , or form a cyclic side chain with R 6 ;
stereocentres 1 *, 2* and 3* are each independently selected from R and S;
n is 1, 2, 3, or 4 and where n is 2-4, each R 7 and each R 8 are independent of each other; and
wherein Z is an amino terminus of an amino acid; —C═O— adjacent L is the carboxy terminus of an amino acid; and L along with Z and —C═O— is a peptide having the following formula:
X y —X z —X 1 —X 2 —X 3
wherein X y and X z are each independently a proteinogenic or non-proteinogenic amino acid, or X z is absent;
X 1 is Leucine or tert-butyl-Ala;
X 2 is Asp; and
X 3 is an amino acid selected from the group consisting of Val, Thr, Ile, Thr(OBn), Thr(OMe), Thr (OEt), Pen, MeThr, alloThr, Abu, and allolle;
wherein the compounds are linked together at a nitrogen atom associated with X y .
2. The multimer of claim 1 , or a pharmaceutically acceptable salt thereof, wherein R 1 is H.
3. The multimer of claim 1 , or a pharmaceutically acceptable salt thereof, wherein R 2 or R 3 is covalently linked to R 1 to form proline having NR 1 as the N-terminus.
4. The multimer of claim 1 , or a pharmaceutically acceptable salt thereof, wherein R 2 and R 3 are not both H.
5. The multimer of claim 1 , or a pharmaceutically acceptable salt thereof, wherein R 2 and R 3 are each independently selected from the group consisting of amino acid side chains of a proteinogenic or a non-proteinogenic alpha-amino acid.
6. The multimer of claim 1 , or a pharmaceutically acceptable salt thereof, wherein R 2 and R 3 are H and CH 3 respectively or vice versa.
7. The multimer of claim 1 , or a pharmaceutically acceptable salt thereof, wherein R 2 or R 3 is —CH 2 —S—R s , wherein R s is selected from C 1 -C 6 alkyl; C 1 -C 6 amino alkyl; aryl; heteroaryl; alkenyl; or heterocycle; all of which are optionally substituted at one or more substitutable positions with one or more substituents selected from the group consisting of hydroxyl; cyano; alkoxy; aryloxy, vinyl; alkenyl; alkynyl; formyl; haloalkyl; halide; aryl; heteroaryl; amide; acyl; ether; thioether; thioalkoxy; phosphino; and —NR a R b , where R a and R b are independently selected from C 1 -C 6 alkyl, aryl or benzyl;
and where the one or more substituents is not alkyl when R 2 , R 3 and/or R s is C 1 -C 6 alkyl; preferably R s is phenyl or phenyl substituted with C 1 -C 6 alkyl, halogen; or C 1 -C 6 amino alkyl.
8. The multimer of claim 1 , or a pharmaceutically acceptable salt thereof, wherein R 4 and R 5 are not both H.
9. The multimer of claim 1 , or a pharmaceutically acceptable salt thereof, wherein R** and R*** are not both H.
10. The multimer of claim 1 , or a pharmaceutically acceptable salt thereof, wherein R 4 and R 5 are each independently H, or C(O)—NHR t , wherein R t is H or a C 1 -C 6 alkyl.
11. The multimer of claim 10 , or a pharmaceutically acceptable salt thereof, wherein R t is tert-butyl.
12. The multimer of claim 10 or a pharmaceutically acceptable salt thereof, wherein R t is H.
13. The multimer of claim 1 , or a pharmaceutically acceptable salt thereof, wherein R 6 is H.
14. The multimer of claim 1 , or a pharmaceutically acceptable salt thereof, wherein R 6 and either R 8 or R 9 form a ring resulting in a proline residue having N—R 6 as its N-terminus.
15. The multimer of claim 1 , or a pharmaceutically acceptable salt thereof, wherein n is 1.
16. The multimer of claim 1 , or a pharmaceutically acceptable salt thereof, wherein X 1 is Leu.
17. The multimer of claim 1 , or a pharmaceutically acceptable salt thereof, wherein X 2 is Asp.
18. The multimer of claim 1 , or a pharmaceutically acceptable salt thereof, wherein X 3 is Thr.
19. The multimer of claim 1 , or a pharmaceutically acceptable salt thereof, wherein X 3 is Val.
20. The multimer of claim 1 , or a pharmaceutically acceptable salt thereof, wherein X 3 is Ile.
21. The multimer of claim 1 , or a pharmaceutically acceptable salt thereof, wherein X y and X z are each independently a proteinogenic or non-proteinogenic alpha-amino acid.
22. The multimer of claim 1 , or a pharmaceutically acceptable salt thereof, wherein X z is a proteinogenic or non-proteinogenic beta-amino acid.
23. The multimer of claim 1 , or a pharmaceutically acceptable salt thereof, wherein X z is betaHomoLys or MethylbetaHomoLys.
24. The multimer of claim 1 , or a pharmaceutically acceptable salt thereof, wherein X y and X z are each a primary amino acid.
25. The multimer of claim 1 , or a pharmaceutically acceptable salt thereof, wherein X y and X z are each any amino acid selected from the group consisting of:
X y
X z
Y
absent
H
absent
F
absent
HomoPhe
absent
Cha
absent
W
absent
1Nal
absent
2Nal
absent
W
absent
Bip
absent
Tyr(OPh)
absent
Tyr(2-tolyl diaryl ether)
absent
Tyr(4-CF3 diaryl ether)
absent
Tyr(4-methoxy diaryl ether)
absent
Tyr(4-fluoro diaryl ether)
absent
Tyr(2-methoxy diaryl ether)
absent
Tyr(3-methoxy diaryl ether)
absent
Tyr(3-fluoro diaryl ether)
absent
Tyr(3,4-difluoro diaryl ether)
absent
Tyr(3-methyl diaryl ether)
absent
Tyr(3,4-dimethyl diaryl ether)
absent
Tyr(4-CO2Me diaryl ether)
absent
Tyr(3-CO2Me diaryl ether)
absent
Tyr(4-CO2H diaryl ether)
absent
metaY(Opr)
absent
Orn(benzamide)
absent
Orn(acetamide)
absent
Orn(methanesulfonamide)
absent
Orn(ethylcarbamate)
absent
Orn(pentyl amide)
absent
R
absent
dTyr
absent
dTic
absent
[3-(3′-pyridyl)-Ala]
absent
dArg
absent
dPip
absent
[3-(4-thiazolyl)-Ala]
absent
(4-aza-Phe)
absent
(vinyl-Br-Leu)
absent
Hyp(OBn)
absent
Dap(Cbz)
absent
His(Bn)
absent
(4-amino-Phe)
absent
(4-aza-dPhe)
absent
Hyp
absent
dTrp
absent
M
absent
dMet
absent
(4-guanidino-Phe)
absent
(3-aza-Phe)
absent
(3-aza-dPhe)
absent
Nva
absent
dNle
absent
dLys
absent
dPro
absent
dOrn
absent
(3-benzothienyl-Ala)
absent
dTyr(OAllyl)
absent
dSer(OBn)
absent
[3-(4-thiazolyl)-dAla]
absent
(3-benzothienyl-dAla)
absent
[3-(2-thienyl)-dAla
absent
(4-aminomethyl-Phe)
absent
dOrn(dimethyl)
absent
(4-amino-dPhe)
absent
(4-aminomethyl-dPhe)
absent
dTyr(OBn)
absent
P
absent
cycloLeu
absent
Aic
absent
Tyr(OAllyl)
absent
Chg
absent
K
absent
(2-aza-dPhe)
absent
(2-aza-Phe)
absent
[2-(2-pyridyl)-4-thiazolyl-Ala]
absent
[2-(3-pyridyl)-4-thiazolyl-Ala]
absent
[2-(4-pyridyl)-4-thiazolyl-Ala]
absent
dTiq
absent
[1-(S)-isoindoline-carboxylic acid]
absent
Y
dThr
Y
P
Y
dPro
Y
Sar
Y
cycloLeu
(3-iodo-Phe)
Sar
(4-iodo-Phe)
Sar
(3,3-diphenyl-Ala)
Sar
F
dLys
Bip
dLys
[3-(4-thiazolyl)-Ala]
dLys
(3,3-diphenyl-Ala)
dLys
Y
dLys
Y
dArg
Y
dSer
Bip
Sar
1Nal
Sar
Y
Pip
(2-iodo-Phe)
Sar
1Nal
dLys
F
Sar
Y
dTic
Y
dPip
F
dPro
(3,4-dimethoxy-Phe)
dPro
(3,4,5-trifluoro-Phe)
dPro
(3,5-dibromo-Tyr)
dPro
F
dPip
[3-(4-thiazolyl)-Ala]
dPip
(4-aminomethyl-Phe)
dPip
[2-iodo-Phe]
dPip
(2-phenyl-Phe)
dPip
[2-(2-methoxy-phenyl)-Phe]
dPip
[2-(3-methoxy-phenyl)-Phe]
dPip
[2-(4-methoxy-phenyl)-Phe]
dPip
Bip
dPip
Y
Hyp
Y
dHyp
Y
(cis-dHyp)
dTyr
dPip
1Nal
dPip
2Nal
dPip
(4-aminomethyl-Phe)
dTic
(3-aminomethyl-Phe)
dTic
(3-aminomethyl-dPhe)
dTic
MeTyr
dPip
Y
dPip
[3-(4-thiazolyl)-Ala]
dHyp
(4-aminomethyl-Phe)
dHyp
Y
dMeLys
Y
dNle
F
dHyp
Y
dMeArg
Y
G
Y
A
Y
dAla
M
G
Tyr(OAllyl)
Sar
Tyr(OAllyl)
G
[3-(4-thiazolyl)-Ala]
Sar
(4-aminomethyl-Phe)
G
Tyr(OAllyl)
dVal
Tyr(OAllyl)
dSer
Tyr(OAllyl)
dAla
Tyr(OAllyl)
P
Tyr(OAllyl)
dPro
[3-(4-thiazolyl)-Ala]
dVal
[3-(4-thiazolyl)-Ala]
dSer
[3-(4-thiazolyl)-Ala]
dAla
[3-(4-thiazolyl)-Ala]
P
[3-(4-thiazolyl)-Ala]
dPro
(4-aminomethyl-Phe)
P
(4-aminomethyl-Phe)
dPro
cycloLeu
P
[2-(2-pyridyl)-4-thiazolyl-Ala]
Sar
[2-(2-pyridyl)-4-thiazolyl-Ala]
dPro
[2-(3-pyridyl)-4-thiazolyl-Ala]
Sar
[2-(3-pyridyl)-4-thiazolyl-Ala]
dPro
[2-(4-pyridyl)-4-thiazolyl-Ala]
dPro
[3-(2-aminobenzyl-4-thiazolyl)-Ala]
Sar
[2-(amino-benzyl)-4-thiazolyl-Ala]
dPro
dTyr
dPip
(2-aminomethyl-Phe)
Aze
(3-aminomethyl-Phe)
dTic
(2,4-dichloro-Phe)
dPip
(3-phenyl-dPhe)
dPip
[3-(5-quinolinyl)-dPhe]
dPip
Y
betaHomoLys
Y
betaHomoPro
Y
2Abz
F
betaHomoLys
[3-(4-thiazolyl)-Ala]
betaHomoLys
(4-aminomethyl-Phe)
betaHomoLys
MeTyr
dbetaHomoLys
1Nal
betaHomoLys
2Nal
betaHomoLys
Bip
betaHomoLys
(2-iodo-Phe)
betaHomoLys
[2-(2,5-dimethyl-isoxazole)-Phe]
betaHomoLys
(2-phenyl-Phe)
betaHomoLys
[(2-piperazinyl-2-Phenyl)-Phe]
betaHomoLys
Cha
betaHomoLys
W
betaHomoLys
dTrp
betaHomoLys
(3-aminomethyl-Phe)
betaHomoLys
(4-aminomethyl-dPhe)
betaHomoLys
(4-aminomethyl-Phe)
betaHomoLys
Y
dbetaHomoLys
dArg
betaHomoLys
(4-aminomethyl-Phe)-reduced
betaHomoLys
[3-(4-thiazolyl)-Ala]
dbetaHomoLys
F
dbetaHomoLys
[3-(4-thiazolyl)-Ala]
MebetaHomoLys
(4-aminomethyl-Phe)
MebetaHomoLys
[3-(4-thiazolyl)-Ala]
betaHomoLys
Tic
betaHomoLys
dTic
betaHomoLys
dTic
dbetaHomoLys
Y
betaHomolle
(4-aminomethyl-Phe)
betaHomoPro
Y
dbetaHomoPro
(4-aminomethyl-Phe)
dbetaHomoPro
R
betaHomoLys
F
MebetaHomoLys
Phe-reduced
betaHomoLys
(3-aminomethyl-dPhe)
betaHomoLys
[2-[3-(1-piperazinyl)phenyl]-Phe]-
betaHomoLys
betaHomoLys
[3-(4-thiazolyl)-dAla]
betaHomoLys
(2-bromo-Phe)
betaHomoLys
(2-chloro-Phe)
betaHomoLys
(2-fluoro-Phe)
betaHomoLys
(2-CF3-Phe)
betaHomoLys
(2,4-dichloro-Phe)
betaHomoLys
(2-aminomethyl-Phe)
betaHomoLys
[2-(4-quinolinyl)-Phe]
betaHomoLys
[2-(5-quinolinyl)-Phe]
betaHomoLys
[2-(3-quinolinyl)-Phe]
betaHomoLys
dhomoPhe
betaHomoLys
(2-iodo-dPhe)
betaHomoLys
(2-phenyl-dPhe)
betaHomoLys
[(2-piperazinyl-2-Phenyl)-dPhe]
betaHomoLys
Y
betaHomoLys
dTyr
betaHomoLys
(4-aminomethyl-dPhe)
betaHomoLys
(4-aminomethyl-Phe)
betaHomoLys
(3-iodo-Phe)
betaHomoLys
(3-phenyl-Phe)
betaHomoLys
[3-(2-methoxy-phenyl)-Phe]
betaHomoLys
[3-(2,6-dimethoxy-phenyl)-Phe]
betaHomoLys
[3-(2-trifluoromethoxy-phenyl)-Phe]
betaHomoLys
(4-iodo-Phe)
betaHomoLys
[4-(2-methoxy-phenyl)-Phe]
betaHomoLys
[4-(2-trifluoromethoxy-phenyl)-Phe]
betaHomoLys
alphaMePhe
betaHomoLys
MePhe
betaHomoLys
[3-(2,6-dimethyl-phenyl)-Phe]
betaHomoLys
[3-(quinolin-4-yl)-Phe]
betaHomoLys
[3-(3,4-difluoro-phenyl)-Phe]
betaHomoLys
[4-(2,6-dimethyl-phenyl)-Phe]
betaHomoLys
[4-(2-chloro-6-methoxy-phenyl)-Phe]
betaHomoLys
[3-(4-thiazolyl)-Ala]-reduced
betaHomoLys
[2-[4-(1-piperazinyl)phenyl]-Phe]
betaHomoLys
[2-(2,6-dimethylphenyl)-Phe]
betaHomoLys
[2-(benzothiazol-5-yl)-Phe]
betaHomoLys
HomoPhe
betaHomoLys
(piperidine-4-amino-4-carboxylic acid)
betaHomoLys
[2-(2,5-dimethyl-isoxazole)-dPhe]
betaHomoLys
[2-(2-chloro-6-methoxyphenyl)-Phe]
betaHomoLys
2Igl
betaHomoLys
d2Igl
betaHomoLys
Atc
betaHomoLys
[2-[2,5-Bis(trifluoromethyl)phenyl]-Phe]
betaHomoLys
Aic
betaHomoLys
P
betaHomoLys
dPro
betaHomoLys
Pip
betaHomoLys
[2-(3-Pyridyl)-Phe]
betaHomoLys
[2-(4-Pyridyl)-Phe]
betaHomoLys
[2-(3-bromo-2-Pyridyl)-Phe]
betaHomoLys
(N-benzyl-Gly)
betaHomoLys
[2-(2-bromo-3-Pyridyl)-Phe]
betaHomoLys
[3-(2-chloro-6-methoxy-phenyl)-Phe]
betaHomoLys
[3-(benzothiazol-5-yl)-Phe]
betaHomoLys
(2-aminomethyl-Phe)
MebetaHomoLys
(2-aminomethyl-dPhe)
MebetaHomoLys
[3-(4-thiazolyl)-dAla]
MebetaHomoLys
[2-(2-trifluoromethoxy-phenyl)-dPhe]
MebetaHomoLys
Tic
MebetaHomoLys
dTic
MebetaHomoLys
[2-(5-quinolinyl)-dPhe]
betaHomoLys
Y
MebetaHomoLys
MeTyr
MebetaHomoLys
MePhe
MebetaHomoLys
(2-fluoro-Phe)
MebetaHomoLys
(2-fluoro-MePhe)
MebetaHomoLys
(2,4-dichloro-Phe)
MebetaHomoLys
(2,4-dichloro-MePhe)
MebetaHomoLys
(2-aminomethyl-MePhe)
MebetaHomoLys
[3-(2,6-dimethoxy-phenyl)-dPhe]
betaHomoLys
[3-(4-Quinolinyl)-dPhe]
betaHomoLys
betaHomoLys
Aze
(3-phenyl-dPhe)
betaHomoLys
[3-(2-trifluoromethoxy-phenyl)-dPhe]
betaHomoLys
[3-(2-methoxy-phenyl)-dPhe]
betaHomoLys
[2-(5-quinolinyl)-MePhe]
MebetaHomoLys
F
betaHomoNle
F
MebetaHomoLys(Me)2
MePhe
MebetaHomoLys(Me)2
M
MebetaHomoLys
Igl
MebetaHomoLys
HomoPhe
MebetaHomoLys
Hyp(OBn)
MebetaHomoLys
(1,2-cis-ACHC)
MebetaHomoLys
MeMet
MebetaHomoLys
betaHomoLys
betaHomoLys
BetaHomoPhe
MebetaHomoLys
betahomoMet
MebetaHomoLys
Y
(3-aminomethyl-4-
bromo-
benzoic acid)
Y
[3-aminomethyl-4-(4-
aza-phenyl)-
benzoic acid]
Y
[3-aminomethyl-4-(2,5-
dimethyl-isoxazole)-
benzoic acid]
Y
[3-aminomethyl-4-(3-
aminomethyl-phenyl)-
benzoic acid]
[3-aminomethyl-4-[4-(1-piperazinyl)-phenyl]-
absent
benzoic acid]
[3-aminomethyl-4-[4-(1-piperazinyl-4-
absent
FITC)phenyl]-benzoic acid]
[3-aminomethyl-4-[4-(1-piperazinyl-4-
absent
AlexaFluor 647)phenyl]-benzoic acid]
[3-aminomethyl-4-(4-quinolinyl)-benzoic
absent
acid]
(3-aminomethyl-4-bromo-benzoic acid)
absent
[3-aminomethyl-4-(2,5-dimethyl-isoxazole)-
absent
benzoic acid]
[3-aminomethyl-4-(4-pyridyl)-benzoic acid]
absent
[3-aminomethyl-(4-methylpyrazole-3-yl)-
absent
benzoic acid]
[3-aminomethyl-4-(3-quinolinyl)-benzoic
absent
acid]
[3-aminomethyl-4-(5-quinolinyl)-benzoic
absent
acid]
[3-aminomethyl-4-[2-(1-piperazinyl)phenyl]-
absent
benzoic acid]
[3-aminomethyl-4-[3-(1-piperazinyl)phenyl]-
absent
benzoic acid]
[3-aminomethyl-4-[2-(3-(piperidin-4-
absent
ylmethoxy)phenyl]-benzoic acid]
[3-aminomethyl-4-[4-(1-piperazinyl)phenyl]-
absent
benzoic acid]
[3-aminomethyl-4-(4-quinolinyl)]-benzoic
absent
acid
(N-benzyl-3-aminomethyl-benzoic acid)
absent
(3-aminomethyl-benzoic acid
absent
(3-aminomethyl-5-bromo-benzoic acid)
absent
(3-aminomethyl-6-bromo-benzoic acid)
absent
[3-aminomethyl-5-(4-aza-phenyl)-benzoic
absent
acid]
[3-aminomethyl-4-(3-thiophenyl)-benzoic
absent
acid]
[3-aminomethyl-4-(4-N,N-dimethyl-
absent
carboxamide-phenyl)-benzoic acid]
[3-aminomethyl-4-(4-aza-phenyl)-benzoic
absent
acid]
[3-aminomethyl-4-(3-aza-phenyl)-benzoic
absent
acid]
[3-aminomethyl-4-(4-hydroxy-phenyl)-
absent
benzoic acid]
[3-aminomethyl-4-[5-(2,4-dimethyl)thiazole]-
absent
benzoic acid]
[3-aminomethyl-4-(3-N,N-dimethylaniline)-
absent
benzoic acid]
[3-aminomethyl-4-(2-fluoro-pyridyl)-benzoic
absent
acid]
[3-aminomethyl-4-(5-pyrimidinyl)-benzoic
absent
acid]
[3-aminomethyl-4-(3-N,N-dimethyl-diaryl
absent
ether)-benzoic acid]
[3-aminomethyl-4-(3-CF3-phenyl)-benzoic
absent
acid]
[3-aminomethyl-4-(2,5-dimethoxy-phenyl)-
absent
benzoic acid]
[3-aminomethyl-4-[(2,3,4-tri-methoxy)-
absent
phenyl]-benzoic acid]
[3-aminomethyl-4-(4-carboxy)-phenyl)-
absent
benzoic acid]
[3-aminomethyl-4-(piperonyl)-benzoic acid]
absent
(3-aminomethyl-4-piperidinyl-benzoic acid)
absent
(3-aminomethyl-4-morpholinyl-benzoic acid)
absent
[3-aminomethyl-4-(N,N-dimethyl)-benzoic
absent
acid]
[3-aminomethyl-4-(2-aminomethylphenyl)-
absent
benzoic acid]
[3-aminomethyl-4-(3-aminomethylphenyl)-
absent
benzoic acid]
[3-aminomethyl-4-(4-aminomethylphenyl)-
absent
benzoic acid]
(N-methyl-3-aminomethyl-benzoic acid)
absent
[N-methyl-3-aminomethyl-4-(4-quinolinyl)-
absent
benzoic acid]
[2-(5-quinolinyl)-Phe]-reduced
betaHomoLys
K
MebetaHomoLys.
26. The multimer of claim 1 , or a pharmaceutically acceptable salt thereof, wherein the compound is any one of compounds 1-3, wherein
R 1 is H;
R 2 is H;
R 3 is CH 2 —S-Ph;
R 4 is H;
R 5 is C(O)—NH-tert-Butyl;
R 6 and R 7 are PRO;
R 8 is H; and
X y , X z , X 1 , X 2 and X 3 are defined as follows:
Cpd No.
X y
X z
X 1
X 2
X 3
1
Y
Absent
L
D
V
2
H
Absent
L
D
V
3
Y
Absent
L
D
T
4
Y
Absent
L
D
T.
27. The multimer of claim 1 , or a pharmaceutically acceptable salt thereof, wherein the compound is any one of compounds 4-16, 18-31, 33-42, 50-141, 143-294, 296-343, 345-350, 352-384, 387-389, or 456 wherein
R 1 is H;
R 2 is H;
R 3 is CH 3 ;
R 4 is H;
R 5 is C(O)—NH-tert-Butyl;
R 6 and R 7 are PRO;
R 8 is H; and
X y , X z , X 1 , X 2 and X 3 are defined as follows:
Cpd.
No.
X y
X z
X 1
X 2
X 3
4
Y
absent
L
D
T
5
F
absent
L
D
T
6
HomoPhe
absent
L
D
T
7
Cha
absent
L
D
T
8
W
absent
L
D
I
9
1Nal
absent
L
D
T
10
2Nal
absent
L
D
T
11
W
absent
L
D
Thr(OBn)
12
Bip
absent
L
D
T
13
Tyr(OPh)
absent
L
D
T
14
1Nal
absent
L
D
I
15
2Nal
absent
L
D
I
16
2Nal
absent
L
D
Thr(OBn)
18
Bip
absent
L
D
Thr(OBn)
19
Tyr(2-tolyl diaryl ether)
absent
L
D
T
20
Tyr(4-CF3 diaryl ether)
absent
L
D
T
21
Tyr(4-methoxy diaryl ether)
absent
L
D
T
22
Tyr(4-fluoro diaryl ether)
absent
L
D
T
23
Tyr(2-methoxy diaryl ether)
absent
L
D
T
24
Tyr(3-methoxy diaryl ether)
absent
L
D
T
25
Tyr(3-fluoro diaryl ether)
absent
L
D
T
26
Tyr(3,4-difluoro diaryl ether)
absent
L
D
T
27
Tyr(3-methyl diaryl ether)
absent
L
D
T
28
Tyr(3,4-dimethyl diaryl ether)
absent
L
D
T
29
Tyr(4-CO 2 Me diaryl ether)
absent
L
D
T
30
Tyr(3-CO 2 Me diaryl ether)
absent
L
D
T
31
Tyr(4-CO 2 H diaryl ether)
absent
L
D
T
33
metaY(Opr)
absent
L
D
T
34
Orn(benzamide)
absent
L
D
Thr(OBn)
35
Orn(acetamide)
absent
L
D
Thr(OBn)
36
Orn(methanesulfonamide)
absent
L
D
Thr(OBn)
37
Orn(ethylcarbamate)
absent
L
D
Thr(OBn)
38
Orn(pentyl amide)
absent
L
D
Thr(OBn)
39
R
absent
L
D
T
40
F
absent
L
D
Thr(OMe)
41
F
absent
L
D
Thr(OEt)
42
dTyr
absent
L
D
T
50
dArg
absent
L
D
T
51
dPip
absent
L
D
T
52
[3-(4-thiazolyl)-Ala]
absent
L
D
T
53
Y
absent
L
D
I
54
(4-aza-Phe)
absent
L
D
T
55
Y
absent
L
D
Pen
56
(vinyl-Br-Leu)
absent
L
D
T
57
Hyp(OBn)
absent
L
D
T
58
Hyp(OBn)
absent
L
D
T
59
Dap(Cbz)
absent
L
D
T
60
His(Bn)
absent
L
D
T
61
(4-amino-Phe)
absent
L
D
T
62
(4-aza-dPhe)
absent
L
D
T
63
Hyp
absent
L
D
T
64
dTrp
absent
L
D
T
65
M
absent
L
D
T
66
dMet
absent
L
D
T
67
(4-guanidino-Phe)
absent
L
D
T
68
(3-aza-Phe)
absent
L
D
T
69
dTic
absent
L
D
T
70
(3-aza-dPhe)
absent
L
D
T
71
Nva
absent
L
D
T
72
dNle
absent
L
D
T
73
dLys
absent
L
D
T
74
dPro
absent
L
D
T
75
dOrn
absent
L
D
T
76
(3-benzothienyl-Ala)
absent
L
D
T
77
dTyr(OAllyl)
absent
L
D
T
78
dSer(OBn)
absent
L
D
T
79
[3-(4-thiazolyl)-dAla]
absent
L
D
T
80
(3-benzothienyl-dAla)
absent
L
D
T
81
[3-(2-thienyl)-dAla
absent
L
D
T
82
(4-aminomethyl-Phe)
absent
L
D
T
83
dOrn(dimethyl)
absent
L
D
T
84
(4-amino-dPhe)
absent
L
D
T
85
(4-aminomethyl-dPhe)
absent
L
D
T
86
dTyr(OBn)
absent
L
D
T
87
P
absent
L
D
T
88
cycloLeu
absent
L
D
T
89
Aic
absent
L
D
T
90
Tyr(OAllyl)
absent
L
D
T
91
Chg
absent
L
D
T
92
K
absent
L
D
T
93
(2-aza-dPhe)
absent
L
D
T
94
(2-aza-Phe)
absent
L
D
T
95
[2-(2-pyridyl)-4-thiazolyl-Ala]
absent
L
D
T
96
[2-(3-pyridyl)-4-thiazolyl-Ala]
absent
L
D
T
97
[2-(4-pyridyl)-4-thiazolyl-Ala]
absent
L
D
T
98
dTiq
absent
L
D
T
99
[1-(S)-isoindoline-carboxylic acid]
absent
L
D
T
100
Y
dThr
L
D
T
101
Y
P
L
D
T
102
Y
dPro
L
D
T
104
Y
cycloLeu
L
D
T
105
Y
Sar
L
D
T
106
(3-iodo-Phe)
Sar
L
D
T
107
(4-iodo-Phe)
Sar
L
D
T
108
(3,3-diphenyl-Ala)
Sar
L
D
T
109
F
dLys
L
D
T
110
Bip
dLys
L
D
T
111
[3-(4-thiazolyl)-Ala]
dLys
L
D
T
112
(3,3-diphenyl-Ala)
dLys
L
D
T
113
Y
dLys
L
D
I
114
Y
dArg
L
D
T
115
Y
dSer
L
D
T
116
Bip
Sar
L
D
T
117
1Nal
Sar
L
D
T
118
Y
Pip
L
D
T
119
(2-iodo-Phe)
Sar
L
D
T
120
1Nal
dLys
L
D
T
121
Y
dLys
L
D
MeThr
122
F
Sar
L
D
T
123
Y
dTic
L
D
T
125
Y
dPip
L
D
T
126
F
dPro
L
D
T
127
(3,4-dimethoxy-Phe)
dPro
L
D
T
128
(3,4,5-trifluoro-Phe)
dPro
L
D
T
129
(3,5-dibromo-Tyr)
dPro
L
D
T
130
F
dPip
L
D
T
131
[3-(4-thiazolyl)-Ala]
dPip
L
D
T
132
(4-aminomethyl-Phe)
dPip
L
D
T
133
[2-iodo-Phe]
dPip
L
D
T
134
(2-phenyl-Phe)
dPip
L
D
T
135
[2-(2-methoxy-phenyl)-Phe]
dPip
L
D
T
136
[2-(3-methoxy-phenyl)-Phe]
dPip
L
D
T
137
[2-(4-methoxy-phenyl)-Phe]
dPip
L
D
T
138
Bip
dPip
L
D
T
139
Y
Hyp
L
D
T
140
Y
dHyp
L
D
T
141
Y
(cis-dHyp)
L
D
T
142
dTyr
dPip
L
D
T
143
1Nal
dPip
L
D
T
144
2Nal
dPip
L
D
T
143
(4-aminomethyl-Phe)
dTic
L
D
T
144
(3-aminomethyl-Phe)
dTic
L
D
T
145
(3-aminomethyl-dPhe)
dTic
L
D
T
146
MeTyr
dPip
L
D
T
147
Y
dPip
L
D
alloThr
148
Y
dPip
tertbutylAla
D
T
149
[3-(4-thiazolyl)-Ala]
dHyp
L
D
T
150
(4-aminomethyl-Phe)
dHyp
L
D
T
151
Y
dPip
L
D
I
152
Y
dMeLys
L
D
I
153
Y
dNle
L
D
T
154
F
dHyp
L
D
T
155
Y
dMeArg
L
D
T
156
Y
G
L
D
T
157
Y
A
L
D
T
158
Y
dAla
L
D
T
159
M
G
L
D
T
160
Tyr(OAllyl)
Sar
L
D
T
161
Tyr(OAllyl)
G
L
D
T
162
[3-(4-thiazolyl)-Ala]
Sar
L
D
T
163
(4-aminomethyl-Phe)
G
L
D
T
164
Tyr(OAllyl)
dVal
L
D
T
165
Tyr(OAllyl)
dSer
L
D
T
166
Tyr(OAllyl)
dAla
L
D
T
167
Tyr(OAllyl)
P
L
D
T
168
Tyr(OAllyl)
dPro
L
D
T
169
[3-(4-thiazolyl)-Ala]
dVal
L
D
T
170
[3-(4-thiazolyl)-Ala]
dSer
L
D
T
171
[3-(4-thiazolyl)-Ala]
dAla
L
D
T
172
[3-(4-thiazolyl)-Ala]
P
L
D
T
173
[3-(4-thiazolyl)-Ala]
dPro
L
D
T
174
(4-aminomethyl-Phe)
P
L
D
T
175
(4-aminomethyl-Phe)
dPro
L
D
T
176
cycloLeu
P
L
D
T
177
[2-(2-pyridyl)-4-thiazolyl-Ala]
Sar
L
D
T
178
[2-(2-pyridyl)-4-thiazolyl-Ala]
dPro
L
D
T
179
[2-(3-pyridyl)-4-thiazolyl-Ala]
Sar
L
D
T
180
[2-(3-pyridyl)-4-thiazolyl-Ala]
dPro
L
D
T
181
[2-(4-pyridyl)-4-thiazolyl-Ala]
dPro
L
D
T
182
[3-(2-aminobenzyl-4-thiazolyl)-Ala]
Sar
L
D
T
183
[2-(amino-benzyl)-4-thiazolyl-Ala]
dPro
L
D
T
184
dTyr
dPip
L
D
I
185
(2-aminomethyl-Phe)
Aze
L
D
T
186
Y
dPip
L
D
Abu
187
(3-aminomethyl-Phe)
dTic
L
D
Abu
188
(2,4-dichloro-Phe)
dPip
L
D
T
189
(3-phenyl-dPhe)
dPip
L
D
T
190
[3-(5-quinolinyl)-dPhe]
dPip
L
D
T
191
Y
betaHomoLys
L
D
T
192
Y
betaHomoPro
L
D
T
193
Y
betaHomoLys
L
D
T
194
Y
2Abz
L
D
T
195
F
betaHomoLys
L
D
T
196
[3-(4-thiazolyl)-Ala]
betaHomoLys
L
D
T
197
(4-aminomethyl-Phe)
betaHomoLys
L
D
T
198
Y
betaHomoLys
L
D
Thr(OBn)
199
MeTyr
dbetaHomoLys
L
D
T
200
1Nal
betaHomoLys
L
D
T
201
2Nal
betaHomoLys
L
D
T
202
Bip
betaHomoLys
L
D
T
203
(2-iodo-Phe)
betaHomoLys
L
D
T
204
[2-(2,5-dimethyl-isoxazole)-Phe]
betaHomoLys
L
D
T
205
(2-phenyl-Phe)
betaHomoLys
L
D
T
206
(2-phenyl-Phe)
betaHomoLys
L
D
T
207
[(2-piperazinyl-2-Phenyl)-Phe]
betaHomoLys
L
D
T
208
Cha
betaHomoLys
L
D
T
209
W
betaHomoLys
L
D
T
210
dTrp
betaHomoLys
L
D
T
211
(3-aminomethyl-Phe)
betaHomoLys
L
D
T
212
(4-aminomethyl-dPhe)
betaHomoLys
L
D
T
213
(4-aminomethyl-Phe)
betaHomoLys
L
D
I
214
Y
dbetaHomoLys
L
D
I
215
dArg
betaHomoLys
L
D
T
216
(4-aminomethyl-Phe)-reduced
betaHomoLys
L
D
T
217
[3-(4-thiazolyl)-Ala]
dbetaHomoLys
L
D
I
218
F
dbetaHomoLys
L
D
I
219
[3-(4-thiazolyl)-Ala]
MebetaHomoLys
L
D
T
220
(4-aminomethyl-Phe)
MebetaHomoLys
L
D
T
221
[3-(4-thiazolyl)-Ala]
betaHomoLys
L
D
I
222
Tic
betaHomoLys
L
D
T
223
dTic
betaHomoLys
L
D
T
224
dTic
dbetaHomoLys
L
D
T
225
Y
betaHomolle
L
D
T
226
(4-aminomethyl-Phe)
betaHomoPro
L
D
T
227
Y
dbetaHomoPro
L
D
T
228
(4-aminomethyl-Phe)
dbetaHomoPro
L
D
T
229
R
betaHomoLys
L
D
T
230
F
MebetaHomoLys
L
D
T
231
Phe-reduced
betaHomoLys
L
D
T
232
(3-aminomethyl-dPhe)
betaHomoLys
L
D
T
233
[2-[3-(1-piperazinyl)phenyl]-Phe]-
betaHomoLys
L
D
T
betaHomoLys
234
[3-(4-thiazolyl)-dAla]
betaHomoLys
L
D
T
235
(2-bromo-Phe)
betaHomoLys
L
D
T
236
(2-chloro-Phe)
betaHomoLys
L
D
T
237
(2-fluoro-Phe)
betaHomoLys
L
D
T
238
(2-CF3-Phe)
betaHomoLys
L
D
T
239
(2,4-dichloro-Phe)
betaHomoLys
L
D
T
240
(2-aminomethyl-Phe)
betaHomoLys
L
D
T
241
[2-(4-quinolinyl)-Phe]
betaHomoLys
L
D
T
242
[2-(5-quinolinyl)-Phe]
betaHomoLys
L
D
T
243
[2-(3-quinolinyl)-Phe]
betaHomoLys
L
D
T
244
dhomoPhe
betaHomoLys
L
D
T
245
(2-iodo-dPhe)
betaHomoLys
L
D
T
246
(2-phenyl-dPhe)
betaHomoLys
L
D
T
247
[(2-piperazinyl-2-Phenyl)-dPhe]
betaHomoLys
L
D
T
248
Y
betaHomoLys
L
D
I
249
Y
betaHomoLys
L
D
V
250
dTyr
betaHomoLys
L
D
I
251
(4-aminomethyl-dPhe)
betaHomoLys
L
D
I
252
(4-aminomethyl-Phe)
betaHomoLys
L
D
V
253
(3-iodo-Phe)
betaHomoLys
L
D
T
254
(3-phenyl-Phe)
betaHomoLys
L
D
T
255
[3-(2-methoxy-phenyl)-Phe]
betaHomoLys
L
D
T
256
[3-(2,6-dimethoxy-phenyl)-Phe]
betaHomoLys
L
D
T
257
[3-(2-trifluoromethoxy-phenyl)-Phe]
betaHomoLys
L
D
T
258
(4-iodo-Phe)
betaHomoLys
L
D
T
259
[4-(2-methoxy-phenyl)-Phe]
betaHomoLys
L
D
T
260
[4-(2-trifluoromethoxy-phenyl)-Phe]
betaHomoLys
L
D
T
261
alphaMePhe
betaHomoLys
L
D
T
262
MePhe
betaHomoLys
L
D
T
263
[3-(2,6-dimethyl-phenyl)-Phe]
betaHomoLys
L
D
T
264
[3-(quinolin-4-yl)-Phe]
betaHomoLys
L
D
T
265
[3-(3,4-difluoro-phenyl)-Phe]
betaHomoLys
L
D
T
266
[4-(2,6-dimethyl-phenyl)-Phe]
betaHomoLys
L
D
T
267
[4-(2-chloro-6-methoxy-phenyl)-Phe]
betaHomoLys
L
D
T
268
[3-(4-thiazolyl)-Ala]-reduced
betaHomoLys
L
D
T
269
[2-[4-(1-piperazinyl)phenyl]-Phe]
betaHomoLys
L
D
T
270
[2-(2,6-dimethylphenyl)-Phe]
betaHomoLys
L
D
T
271
[2-(benzothiazol-5-yl)-Phe]
betaHomoLys
L
D
T
272
HomoPhe
betaHomoLys
L
D
T
273
(piperidine-4-amino-4-carboxylic acid)
betaHomoLys
L
D
T
274
[2-(2,5-dimethyl-isoxazole)-dPhe]
betaHomoLys
L
D
T
275
dTyr
betaHomoLys
L
D
V
276
(4-aminomethyl-dPhe)
betaHomoLys
L
D
T
277
[2-(2-chloro-6-methoxyphenyl)-Phe]
betaHomoLys
L
D
T
278
2Igl
betaHomoLys
L
D
T
279
d2Igl
betaHomoLys
L
D
T
280
Atc
betaHomoLys
L
D
T
281
Y
betaHomoLys
L
D
allolle
282
dTyr
betaHomoLys
L
D
allolle
283
(4-aminomethyl-Phe)
betaHomoLys
L
D
allolle
284
[2-[2,5-Bis(trifluoromethyl)phenyl]-Phe]
betaHomoLys
L
D
T
285
[2-[2,5-Bis(trifluoromethyl)phenyl]-Phe]
betaHomoLys
L
D
T
286
Aic
betaHomoLys
L
D
T
287
P
betaHomoLys
L
D
T
288
dPro
betaHomoLys
L
D
T
289
Pip
betaHomoLys
L
D
T
290
[2-(3-Pyridyl)-Phe]
betaHomoLys
L
D
T
291
[2-(4-Pyridyl)-Phe]
betaHomoLys
L
D
T
292
[2-(3-bromo-2-Pyridyl)-Phe]
betaHomoLys
L
D
T
293
2Nal
dPip
L
D
T
294
(4-aminomethyl-Phe)
dTic
L
D
T
Cpd No.
X y
X z
X 1
X 2
X 3
456
K
Mebeta-
L
D
T.
HomoLys
28. The multimer of claim 1 , or a pharmaceutically acceptable salt thereof, wherein the compound is compound 17 wherein
R 1 is H;
R 2 is H;
R 3 is CH 3 ;
R 4 is H;
R 5 is C(O)—NH-tert-Butyl;
R 6 and R 7 are [(4S)-fluoro-Pro];
R 8 is H; and
X y , X z , X 1 , X 2 and X 3 are defined as follows:
Cpd No.
X y
X z
X 1
X 2
X 3
17
W
absent
L
D
T.
29. The multimer of claim 1 , or a pharmaceutically acceptable salt thereof, wherein the compound is any one of compounds 32 or 44 wherein
R 1 is H;
R 2 is H;
R 3 is CH 3 ;
R 4 is H;
R 5 is C(O)—NH-tert-Butyl;
R 6 and R 7 are HYP;
R 8 is H; and
X y , X z , X 1 , X 2 and X 3 are defined as follows:
Cpd No.
X y
X z
X 1
X 2
X 3
32
F
absent
L
D
T
44
[3-(3′-pyridyl)-Ala]
absent
L
D
T.
30. The multimer of claim 1 , or a pharmaceutically acceptable salt thereof, wherein the compound is any one of compounds 43, 103, 124, wherein
R 1 is H;
R 2 is CH 3 ;
R 3 is H;
R 4 is H;
R 5 is C(O)—NH-tert-Butyl;
R 6 and R 7 are PRO;
R 8 is H; and
X y , X z , X 1 , X 2 and X 3 are defined as follows:
Cpd No.
X y
X z
X 1
X 2
X 3
43
dTic
absent
L
D
T
103
Y
Sar
L
D
T
124
Y
dPro
L
D
T.
31. The multimer of claim 1 , or a pharmaceutically acceptable salt thereof, wherein the compound is any one of compounds 45-48 wherein
R 1 is H;
R 2 is H;
R 3 is CH 3 ;
R 4 is H;
R 5 is C(O)—NH-tert-Butyl;
R 6 and R 7 are [(4R)-fluoro-Pro];
R 8 is H; and
X y , X z , X 1 , X 2 and X 3 are defined as follows:
Cpd No.
X y
X z
X 1
X 2
X 3
45
F
absent
L
D
T
46
Bip
absent
L
D
T
47
[3-(3′-pyridyl)-Ala]
absent
L
D
T
48
Y
absent
L
D
T.
32. The multimer of claim 1 , or a pharmaceutically acceptable salt thereof, wherein the compound is compound 49 wherein
R 1 is H;
R 2 is H;
R 3 is CH 3 ;
R 4 is H;
R 5 is C(O)—NH-tert-Butyl;
R 6 and R 7 are [(4S)-fluoro-Pro];
R 8 is H; and
X y , X z , X 1 , X 2 and X 3 are defined as follows:
Cpd No.
X y
X z
X 1
X 2
X 3
49
Y
absent
L
D
T.
33. The multimer of claim 1 , or a pharmaceutically acceptable salt thereof, wherein the compound is compound 142 or 344 wherein
R 1 is H;
R 2 is CH 3 ;
R 3 is H;
R 4 is C(O)—NH-tert-Butyl;
R 5 is H;
R 6 is dPRO
R 7 is H;
R 8 is dPRO; and
X y , X z , X 1 , X 2 and X 3 are defined as follows:
Cpd No.
X y
X z
X 1
X 2
X 3
142
dTyr
dPip
L
D
T
344
[3-aminomethyl-4-(4-
absent
L
D
T.
pyridyl)-benzoic acid]
34. The multimer of claim 1 , or a pharmaceutically acceptable salt thereof, wherein the compound is compound 295 wherein
R 1 and R 2 are PRO—;
R 3 is H;
R 4 is H;
R 5 is C(O)—NH-tert-Butyl;
R 6 and R 7 are PRO;
R 8 is H; and
X y , X z , X 1 , X 2 and X 3 are defined as follows:
Cpd No.
X y
X z
X 1
X 2
X 3
295
Y
dbetaHomoLys
L
D
T.
35. The multimer of claim 1 , or a pharmaceutically acceptable salt thereof, wherein the compound is compound 344 wherein
R 1 is H;
R 2 is CH 3 ;
R 3 is H;
R 4 is C(O)—NH-tert-Butyl;
R 5 is H;
R 6 are dPRO;
R 7 is H;
R 8 is dPRO; and
X y , X z , X 1 , X 2 and X 3 are defined as follows:
Cpd No.
X y
X z
X 1
X 2
X 3
344
[3-aminomethyl-4-(4-
absent
L
D
T.
pyridyl)-benzoic acid]
36. The multimer of claim 1 , or a pharmaceutically acceptable salt thereof, wherein the compound is compound 351 wherein
R 1 is H;
R 2 is CH 3 ;
R 3 is H;
R 4 is C(O)—NH-tert-Butyl;
R 5 is H;
R 6 and R 7 are PRO;
R 8 is H; and
X y , X z , X 1 , X 2 and X 3 are defined as follows:
Cpd No.
X y
X z
X 1
X 2
X 3
351
[3-aminomethyl-4-(4-
absent
L
D
T.
pyridyl)-benzoic acid]
37. The multimer of claim 1 , or a pharmaceutically acceptable salt thereof, wherein the compound is compound 385 wherein
R 1 is H;
R 2 is H;
R 3 is CH 3 ;
R 4 is H;
R 5 is C(O)—NH-tert-Butyl;
R 6 is H;
R 7 is Nva;
R 8 is H; and
X y , X z , X 1 , X 2 and X 3 are defined as follows:
Cpd No.
X y
X z
X 1
X 2
X 3
385
[3-aminomethyl-4-(4-
absent
L
D
T.
quinolinyl)-benzoic
acid]
38. The multimer of claim 1 , or a pharmaceutically acceptable salt thereof, wherein the compound is compound 386 wherein
R 1 is H;
R 2 is H;
R 3 is CH 3 ;
R 4 is H;
R 5 is C(O)—NH-tert-Butyl;
R 6 and R 7 are PRO;
R 5 is H; and
X y , X z , X 1 , X 2 and X 3 are defined as follows:
Cpd No.
X y
X z
X 1
X 2
X 3
386
[3-aminomethyl-4-[4-
absent
L
D
T.
(1-piperazinyl-4-
AlexaFluor
647)phenyl]-benzoic
acid]
39. The multimer of claim 1 , or a pharmaceutically acceptable salt thereof, wherein the compound is any one of compounds 390-392, or 458-538 wherein
R 1 is H;
R 2 is H;
R 3 is CH 3 ;
R 4 is H;
R 5 is C(O)—NH-tert-Butyl;
R 6 and R 7 are PRO;
R 5 is H; and
X y , X z , X 1 , X 2 and X 3 are defined as follows:
TABLE 2B
Cpd.
No.
X y
X z
X 1
X 2
X 3
390
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
391
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
392
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
458
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
458
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
459
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
460
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
461
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
462
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
463
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
464
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
465
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
466
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
467
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
468
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
469
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
470
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
471
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
472
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
473
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
474
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
475
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
476
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
477
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
478
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
479
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
480
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
481
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
482
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
483
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
484
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
485
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
486
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
487
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
488
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
489
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
490
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
491
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
492
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
493
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
494
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
495
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
496
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
497
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
498
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
499
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
500
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
501
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
502
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
503
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
504
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
505
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
506
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
507
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
508
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
509
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
510
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
511
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
512
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
513
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
514
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
515
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
516
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
517
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
518
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
519
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
520
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
521
[3-
absent
L
D
T
aminomethyl-
4-[4-(1-
piperazinyl)-
phenyl]-
benzoic acid]
522
(4-aminomethyl-Phe)
absent
L
D
T
523
(4-aminomethyl-Phe)
absent
L
D
T
524
(4-aminomethyl-Phe)
absent
L
D
T
525
(4-aminomethyl-Phe)
absent
L
D
T
526
(4-aminomethyl-Phe)
absent
L
D
T
527
(3-aminomethyl-Phe)
absent
L
D
T
528
(3-aminomethyl-Phe)
absent
L
D
T
529
(3-aminomethyl-Phe)
absent
L
D
T
530
K
absent
L
D
T
531
K
absent
L
D
T
532
K
absent
L
D
T
533
K
absent
L
D
T
534
K
absent
L
D
T
535
K
absent
L
D
T
536
K
absent
L
D
T
537
K
absent
L
D
T
538
[3-aminomethyl-4-[4-(1-
absent
L
D
T.
piperazinyl)-phenyl]-benzoic acid]